DrugPatentWatch Database Preview
ADEFOVIR DIPIVOXIL Drug Profile
see a sample report or, see our see our flat-rate plans
Which patents cover Adefovir Dipivoxil, and what generic alternatives are available?
The generic ingredient in ADEFOVIR DIPIVOXIL is adefovir dipivoxil. There are eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the adefovir dipivoxil profile page.
Summary for ADEFOVIR DIPIVOXIL
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 91 |
| Clinical Trials: | 77 |
| Patent Applications: | 3,895 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ADEFOVIR DIPIVOXIL |
| DailyMed Link: | ADEFOVIR DIPIVOXIL at DailyMed |
Pharmacology for ADEFOVIR DIPIVOXIL
| Ingredient-type | Nucleoside Analog |
| Drug Class | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor |
| Mechanism of Action | Nucleoside Reverse Transcriptase Inhibitors |
Synonyms for ADEFOVIR DIPIVOXIL
| ((((2-(6-amino-9H-purin-9-yl)ethoxy)methyl)phosphoryl)bis(oxy))bis(methylene) bis(2,2-dimethylpropanoate) |
| (((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphinylidene)bis(oxymethylene) 2,2-dimethylpropanoate |
| (((2-(6-AMINO-9H-PURIN-9-YL)ETHOXY)METHYL)PHOSPHORYL)BIS(OXY)BIS(METHYLENE) BIS(2,2-DIMETHYLPROPANOATE) |
| ((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)phosphonic acid, diester with hydroxymethyl pivalate |
| (2-(6-AMINOPURIN-9-YL)ETHOXYMETHYL-(2,2-DIMETHYLPROPANOYLOXYMETHOXY)PHOSPHORYL)OXYMETHYL2,2-DIMETHYLPROPANOATE |
| [({[2-(6-amino-9H-purin-9-yl)ethoxy]methyl}({[(2,2-dimethylpropanoyl)oxy]methoxy})phosphoryl)oxy]methyl 2,2-dimethylpropanoate |
| [2-(6-aminopurin-9-yl)ethoxymethyl-(2,2-dimethylpropanoyloxymethoxy)phosphoryl]oxymethyl 2,2-dimethylpropanoate |
| 142340-99-6 |
| 2,2-dimethylpropanoic acid [2-(6-aminopurin-9-yl)ethoxymethyl-[(2,2-dimethyl-1-oxopropoxy)methoxy]phosphoryl]oxymethyl ester |
| 3-{[2-(6-amino-9H-purin-9-yl)ethoxy]methyl}-8,8-dimethyl-3-oxido-7-oxo-2,4,6-trioxa-3-phosphanon-1-yl pivalate (non-preferred |
| 3-{[2-(6-amino-9H-purin-9-yl)ethoxy]methyl}-8,8-dimethyl-3-oxido-7-oxo-2,4,6-trioxa-3?5-phosphanon-1-yl 2,2-dimethylpropanoate |
| 3-{[2-(6-amino-9H-purin-9-yl)ethoxy]methyl}-8,8-dimethyl-3-oxido-7-oxo-2,4,6-trioxa-3lambda~5~-phosphanon-1-yl 2,2-dimethylpropanoate |
| 340A996 |
| 9-(2-((-Bis((pivaloyloxy)methoxy)phosphinyl)methoxy)ethyl)adenine |
| 9-(2-((Bis((pivaloyloxy)methoxy)phosphinyl)methoxy)ethyl)adenine |
| 9-(2[bis(Pivaloyloxymethoxy)phosphorylmethoxy]ethyl)adenine |
| 9-[2-[Bis(pivaloyloxymethoxy)phosphorylmethoxy]ethyl]adenine |
| 9-[2-[BIS[(PIVALOYLOXY)METHOXY]PHOSPHINYL]METHOXY]ETHYL]ADENINE |
| A807894 |
| AB0012816 |
| AB01274706_02 |
| AB01274706-01 |
| AB07592 |
| AB2000245 |
| AC-1693 |
| AC1L1U36 |
| adefovir depivoxil |
| Adefovir di(pivaloyloxymethyl) ester |
| Adefovir Dipivoxil (Preveon, Hepsera) |
| Adefovir dipivoxil (USAN) |
| Adefovir dipivoxil [USAN] |
| Adefovir dipivoxil, Antibiotic for Culture Media Use Only |
| Adefovir dipivoxyl |
| Adefovir pivoxil |
| Adefovir pivoxil (JAN) |
| Adefovirdipivoxl |
| AKOS005145737 |
| Ambap142340-99-6 |
| AN-6719 |
| ANW-43238 |
| API0001387 |
| ARONIS27063 |
| B2222 |
| BC206225 |
| BCP0726000157 |
| BCP9000232 |
| BCPP000434 |
| bis-POM PMEA |
| Bis-POM PMEA, Adefovir Dipivoxil |
| Bis-POM PMEA, Preveon, Hepsera, Adefovir Dipivoxil |
| Bis-POM PMEA;Preveon;Hepsera;Preveon;Hepsera |
| Bis(pivaloyloxymethyl)-9-(2-phosphonylmethoxyethyl)adenine |
| BIS(PIVALOYLOXYMETHYL)-9-[2-(PHOSPHONOMETHOXY)ETHYL]ADENINE |
| Bis(POM)-PMEA |
| Bis(pom)PMEA |
| C-22950 |
| C20H32N5O8P |
| CA0117 |
| CAS-142340-99-6 |
| CC-23770 |
| CHEMBL922 |
| CS-2240 |
| CTK8B3813 |
| D01655 |
| D0ML1F |
| DB00718 |
| DIPIVOXIL |
| DR003071 |
| DSSTox_CID_26487 |
| DSSTox_GSID_46487 |
| DSSTox_RID_81658 |
| DTXSID5046487 |
| FT-0082875 |
| FT-0631164 |
| GP5823 |
| GS 0840 |
| GS 840 |
| GS-0840 |
| GS-3604 |
| GS-840 |
| HE310667 |
| Hepsera |
| Hepsera (TM) |
| Hepsera (TN) |
| HMS3604F09 |
| HMS3655I04 |
| HY-B0255 |
| I06-1150 |
| I14-3234 |
| KS-00000L27 |
| KS-000048K6 |
| LS-173141 |
| MCULE-6257358029 |
| MFCD00869897 |
| MLS003915635 |
| MLS004774124 |
| NCGC00164624-01 |
| NCGC00164624-02 |
| NCGC00164624-03 |
| Piv2PMEA |
| Preveon |
| Preveon (TN) |
| Propanoic acid, 2,2-dimethyl-, (((2-(6-amino-9H-purin-9-yl)ethoxy)methyl)phosphinylidene)bis(oxymethylene) ester |
| Propanoic acid,2,2-dimethyl-(((2-(6-amino-9H-purin-9-yl)ehtoxy)mehtyl)phosphinyldiene)bis(oxymehtylene)ester |
| PubChem14224 |
| Q-101927 |
| RP17773 |
| RTC-070886 |
| s1718 |
| SCHEMBL29729 |
| SMR002530072 |
| SR-01000931258 |
| SR-01000931258-2 |
| STL257088 |
| TC-070886 |
| TL8000938 |
| Tox21_112243 |
| Tox21_112243_1 |
| U6Q8Z01514 |
| UNII-U6Q8Z01514 |
| W-2203 |
| YouHeDing |
| ZINC3930376 |
US Patents and Regulatory Information for ADEFOVIR DIPIVOXIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apotex Inc | ADEFOVIR DIPIVOXIL | adefovir dipivoxil | TABLET;ORAL | 205459-001 | Jul 6, 2018 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Sigmapharm Labs Llc | ADEFOVIR DIPIVOXIL | adefovir dipivoxil | TABLET;ORAL | 202051-001 | Aug 29, 2013 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
see a sample report or, see our see our flat-rate plans
